Your browser doesn't support javascript.
loading
Absence of hemoglobin increase is associated with reduced graft survival after kidney transplantation.
Goldman, Shira; Schechter, Amir; Steinmetz, Tali; Agur, Timna; Shepshelovich, Daniel; Gafter-Gvili, Anat; Hanniel, Iddo; Rozen-Zvi, Benaya; Rahamimov, Ruth.
Afiliação
  • Goldman S; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Schechter A; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Steinmetz T; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Agur T; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Shepshelovich D; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Gafter-Gvili A; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Hanniel I; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Rozen-Zvi B; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Rahamimov R; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Clin Transplant ; 36(5): e14602, 2022 05.
Article em En | MEDLINE | ID: mdl-35073452
ABSTRACT

BACKGROUND:

Anemia is prevalent following kidney transplantation and is associated with reduced graft survival. The association between temporal changes in hemoglobin (Hb) level at the early post-transplant period and graft survival is unknown. PATIENTS AND

METHODS:

The study cohort included consecutive patients included in a single center transplantation registry between January 2002 and December 2016. Temporal changes in Hb values during the first 90 days after the transplantation were evaluated by piecewise linear regression model. Significant Hb increase rate was defined as an increase of .5 gram/deciliter/month. Patients were divided into groups according to the presence of significant Hb increase. The primary outcome was death-censored graft failure.

RESULTS:

Of 946 patients included in the study cohort, 831 (87.8%) had at least one interval of Hb increase, and 115 (12.2%) had no Hb increase. The absence of Hb increase was associated with an elevated risk of death censored graft failure by univariate (HR 2.9, 95% CI 1.88-4.49, P < .001) and multivariate (HR 2.47, 95% CI 1.48-4.12, P = .001) analyses. The timing and rate of Hb increase had no association with the main outcome.

CONCLUSIONS:

Lack of Hb increase during the early post-transplant period is associated with an increased risk of graft loss.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Anemia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Anemia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel